Why We Invested: ArcHouse
We are thrilled to profile our recent investment in ArcHouse in this edition of our Why We Invested series.
Hospice providers sit at the center of one of the fastest-growing segments in healthcare, yet the patient admissions process today remains highly fragmented and manual. Patient referrals arrive via fax and email, medical records are fragmented across various providers’ systems, and eligibility decisions depend on overburdened staff piecing together information under compressed timelines. ArcHouse eliminates this friction with an AI-native pre-admissions platform that centralizes patient referrals, collects medical records, extracts and summarizes clinical data, and automates insurance eligibility checks. The result is improved patient admission rates, faster onboarding, and more patient days of care – a direct and measurable ROI for providers. ArcHouse has successfully identified a mission-critical workflow in a massive, underserved market and we are extremely excited to be supporting this team as they build the next generation operating system for hospice care.
The Story Behind ArcHouse
ArcHouse was founded by Paul Mocur and Ralph Haddad, who together bring a unique blend of deep operating expertise in healthcare as well as building and scaling technology products. Paul has spent a majority of his career in the post acute care space, serving as a Growth & Operations leader at Metro Medical Equipment, which is a leading regional durable medical equipment provider. Over the course of his career, Paul has engaged extensively with hospice care administrators and senior leadership, gaining direct insight into the operational complexities and pain points these organizations routinely encounter. Ralph’s career has been defined by working at the leading edge of technology and innovation, including his role as Chief of Staff at L37 Ventures (an early stage venture capital fund) and his experience co-founding Numeral Studio, a product strategy and design studio.
In order to serve the two million (and rapidly growing) annual U.S. hospice care patients, the Company is focused on a high priority pain point that is central to hospice business operations: the patient pre-admissions process. The long term vision is to become the end to end technology platform for all pre-admissions, post-admissions, and back office hospice operations.
How ArcHouse Supports Hospice Care Teams
ArcHouse is an AI-native platform acting as a system-of-action for hospice care operators. Admissions teams first engage with ArcHouse’s Centralized Referrals Inbox, a module that continuously monitors and aggregates referrals from fax, email and patient discharge portals into a single system with real time visibility into incoming patients. Once a referral is captured, the Patient Information Intake module analyzes the referral packet and automatically extracts key patient information.
Next, the platform proceeds to the Medical Records Collection and Assessment module, identifying missing medical records information and autonomously retrieving it or conducting outbound outreach to the appropriate providers. Once the necessary records are gathered, ArcHouse’s AI-native platform instantly analyzes the large and complex documents to generate a clear summary of the patient’s health history and conditions, helping determine both hospice eligibility and whether the organization can safely and effectively care for the patient. This allows the Clinical Director to review the key patient information and quickly make an informed admissions decision.
The pre-admissions product concludes with the Insurance Eligibility Check module, which autonomously verifies a patient’s insurance coverage and eligibility. Accurate eligibility verification is foundational to hospice pre-admissions, helping organizations avoid claim denials, compliance issues, financial losses, and delays in care.
ArcHouse is transforming a process that typically takes hospice teams several days and reducing it to a matter of hours. Patients are accessing care at unprecedented speed, while hospice providers are increasing top line growth and improving operating efficiencies.
Beyond its core functionality today, ArcHouse is rapidly expanding its pre-admissions modules to become a true end-to-end system of record and action. In response to strong customer demand, the company has accelerated development of its referral intelligence platform, an operating system managing all of pre-admissions, and is building additional ArcHouse agents to further offload the manual work admissions teams handle today. These capabilities represent just the beginning of a broader suite of AI-powered modules that will unlock new efficiencies and transform workflows across the hospice industry.
Why Now?
Struck Capital is proud to co-lead ArcHouse’s $2.7mm Seed round at a pivotal moment in hospice care. Demand for hospice services is accelerating as average daily patient census counts rise, while providers face mounting pressure to process more referrals and admit patients faster. Legacy, manual intensive pre-admissions workflows simply cannot scale with the projected growth in patient census. By automating referral intake and the downstream pre-admissions workflow, ArcHouse gives providers a scalable, AI-enabled path to grow their census without being constrained by manual processes or staffing gaps.
With an aging U.S. population and a continued policy shift toward value-based care, these macro tailwinds are expected to propel the U.S. hospice market from $8bn to $33bn within the next eight years, implying a 10.3% CAGR. Behind these headline growth projections are real patients with immediate, critical needs for the highest standard of care and hospice providers who are struggling to meet rising demand with sub-scale, manual processes and outdated technology.
We believe ArcHouse’s founding team brings a rare combination of deep post acute care domain expertise and exceptional product acumen. Their ability to identify and solve critical pain points for admissions teams positions them to define the next generation of hospice care technology platforms. Struck Capital is proud to support ArcHouse as they work to become the industry standard end-to-end operations platform, transforming how hospice organizations deliver care to every patient.